Vis enkel innførsel

dc.contributor.authorJansrud, Ida
dc.contributor.authorHalvorsen, Thomas
dc.contributor.authorVollsæter, Maria
dc.contributor.authorHilland, Magnus
dc.contributor.authorHeimdal, John-Helge
dc.contributor.authorRøksund, Ola Drange
dc.contributor.authorClemm, Hege Synnøve Havstad
dc.date.accessioned2022-08-05T10:45:19Z
dc.date.available2022-08-05T10:45:19Z
dc.date.created2022-05-20T11:12:53Z
dc.date.issued2022
dc.identifier.issn0905-7188
dc.identifier.urihttps://hdl.handle.net/11250/3010339
dc.description.abstractPurpose: Exercise-induced bronchoconstriction (EIB) and exercise-induced laryngeal obstruction (EILO) are the two disorders commonly considered when athletes complain of exertional dyspnea. They are highly different but often confused. We aimed to address this diagnostic challenge and its consequences in elite athletes. Methods: We included all athletes competing at national or international level, referred to our institution for workup for EILO during 2013–2016. We diagnosed EILO from video-recorded laryngoscopy performed during maximal cardiopulmonary treadmill exercise (CLE test). Symptoms and previous diagnostic evaluations were obtained from referral letters and chart reviews. Results: Exercise-induced laryngeal obstruction was diagnosed in 73/101 referred athletes, of whom 70/73 had moderate/severe supraglottic obstruction and 3/73 had primarily glottic obstruction with only minor supraglottic involvement. Of the 73 athletes with EILO, we were able to identify objective tests for asthma in 55 participants, of whom 22 had findings supporting asthma. However, 58/73 had used asthma therapy at some time previously, with current use in 28. Only three reported that asthma medication had improved their exercise-related breathing problems, two of whom with tests confirming asthma. Treatment for EILO improved breathing problems in all but four. Conclusions: Objective testing verified EILO in most of the referred athletes. EILO coexisting with asthma was common, and large proportions had used asthma medication; however, few reported effect on exercise-related breathing problems. Unexplained persistent exertional dyspnea must not lead to indiscriminate escalation of asthma treatment, but instead incite investigation for EILO, either as a co-morbidity or as a differential diagnosis.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.no*
dc.titleConundrums in the breathless athlete; exercise-induced laryngeal obstruction or asthma?en_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2022 The Author(s)en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.doi10.1111/sms.14137
dc.identifier.cristin2025920
dc.source.journalScandinavian Journal of Medicine & Science in Sportsen_US
dc.source.pagenumber1041-1049en_US
dc.identifier.citationScandinavian Journal of Medicine & Science in Sports. 2022, 32 (6), 1041-1049.en_US
dc.source.volume32en_US
dc.source.issue6en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal